entertainment -WSS

entertainment

author：hotspot 2025-09-27 17:03:05 - browse：58

Eli Lilly headquarters — Kristoffer Tripplaar/AP

The drug giant Eli Lilly said Thursday that its diabetes drug Mounjaro helped patients with the condition lose 15.7% of their body weight in a clinical trial, a result that Wall Street analysts expect to pave the way for the therapy’s approval as a weight loss treatment.

Mounjaro is the latest drug in a class known as GLP-1s or incretins — the same class as Novo Nordisk’s Ozempic, which has become a sensation because of its ability to help patients lose weight. Mounjaro has shown the potential to lead to even greater weight loss than Ozempic, and industry experts expect that it will eventually generate many billions of dollars in annual sales. Analysts at SVB Securities projected in December that Mounjaro sales could reach $26.4 billion by 2030.

Eli Lilly on Thursday also announced quarterly earnings of $1.64 per share, adjusted for one-time items, slightly below analyst expectations, on sales of $6.96 billion. Sales were hurt because of a comparison to a year ago, when the company’s Covid-19 monoclonal antibodies were still on the market. Mounjaro sales for the first quarter were $586 million, largely for people with diabetes, compared to an analyst consensus of $433.2 million.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Liquid biopsy for lung cancer is launched by Delfi

WSS

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

STAT's guide to the next generation of CAR

FDA rejects Alnylam's heart disease treatment over insufficient data

Weight bias in eating disorder treatment complicated by new weight loss drugs

FDA authorizes Novavax’s updated Covid

What to expect at HLTH 2023, the health care industry conference

entertainment

entertainment

focus

In age of alternative facts, a scholarly course on calling out crap

AI can decode, harness the power of the humane immune system

Guidelines to prevent youth baseball injuries need more muscle

AI can decode, harness the power of the humane immune system

Supreme Court strikes down use of affirmative action

What is the Wagner Group? The 'brutal' Russian military unit in Ukraine

Medicare proposal to cover medical devices draws a mixed reaction

What would happen to your eyes if you looked at the solar eclipse?

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Senate panel eyes new effort on drug shortages

explore

Study: Lilly Alzheimer's therapy slowed patients' cognitive decline

What to expect at HLTH 2023, the health care industry conference

#NeedHerScience: shining a light on gender disparities in medicine

Why are elite athletes different? Take a look at their microbes

WATCH: Why do fingernails fall off when they're damaged?

STAT's guide to the next generation of CAR

explore

hotspot

leisure time

Wikipedia